The Global Mammalian Cell Fermentation Technology Market Size is is predicted to exhibit at a 5% CAGR during the forecast period for 2024-2031.
Mammalian cell fermentation is a crucial component of the production of biopharmaceuticals because it is frequently utilized to produce a range of biosimilars, enzymes, vaccines, and other biologics. The procedure uses mammalian cells grown in-vitro with cell culture media which are then treated for fermentation in a bioreactor. The cells use a number of metabolic pathways during this process to create the required byproducts.
With the aid of mammalian cell fermentation technology, novel therapies are being developed due to the biopharmaceutical industry's high levels of research and development (R&D) spending and numerous funding options. The market for mammalian cell fermentation technology is anticipated to develop quickly throughout the projected period due to the expanding demand for innovative and secure treatments across many geographies.
Significant demand for mammalian culture bioprocessing technology is also projected in the market because of these regions' rapid economic development and rising healthcare expenditures.
Furthermore, strategic actions done by important market participants are likely to increase the industry's potential for generating money. For instance, a California-based CDMO called Culture Biosciences piloted its mammalian cell fermentation services in 2020 to take advantage of the expanding market opportunity. Such actions are anticipated to increase the market's growth prospects shortly.
The mammalian cell fermentation technology market is segmented on the basis of type, application and end-use. Based on type, the market is segregated as Chinese Hamster Ovary (CHO) Cell Fermentation, Human Embryonic Kidney (HEK) Cell Fermentation, Baby Hamster Kidney (BHK) Cell Fermentation, Murine Myeloma Cell Fermentation, Medical Research Council Cell Strain - 5 (MRC-5) Fermentation and Others. By application, the market is segmented into Monoclonal Antibodies, Recombinant Proteins, Biosimilars, Vaccines, Enzymes and Others. By end-use, the market is segmented into Biopharmaceutical Companies, CMOs & CDMOs and Academic and Research Institutes.
The biosimilars category is expected to hold a significant share of the global mammalian cell fermentation technology market in 2024. This segment is expected to expand as a result of factors such as rising demand for biologic medications, biologic medications' patent expirations, and government measures to encourage the use of biosimilars. The ability to produce vast quantities of high-quality biologic pharmaceuticals makes mammalian cell fermentation technology crucial for developing biosimilars. Mammalian cell fermentation technology is anticipated to be used more frequently to produce biosimilars as consumer demand for them rises. This is anticipated to fuel market expansion for mammalian cell fermentation technology, notably in the biosimilars sector.
The CMOs & CDMOs segment is projected to grow at a rapid rate in the global mammalian cell fermentation technology market. CMOs and CDMOs are quickly evolving into the preferred choice for biotherapeutics producers because smaller businesses produce the majority of innovation in the bioprocess industry that lack the capacity, skilled personnel, and resources necessary for the commercialization of these products. The mammalian cell fermentation technology market's rise in this category is also anticipated to be aided by biologics' steadily expanding clinical pipeline.
The North America mammalian cell fermentation technology market is expected to register the highest market share in revenue in the near future, attributed to the region's large number of contract development companies and the growing engagement of enterprises in biologics research and product development. The robust regulatory framework in North America significantly impacts the market for mammalian cell fermentation technology.
The biggest markets in the area are the United States, Canada, and Mexico. The rising demand for biologic medications, technical improvements, and governmental assistance for biotechnology research and development additionally fuels the market. In addition, Asia Pacific is projected to grow at a rapid rate in the global mammalian cell fermentation technology market. This expansion is fueled by various variables, including a sizable patient population, rising demand for biologic medications, government programs to assist biotechnology research and development, and increased contract manufacturing organizations (CMOs) in the area.
|
Report Attribute |
Specifications |
|
Growth rate CAGR |
CAGR of 5% from 2024 to 2031 |
|
Quantitative units |
Representation of revenue in US$ Billion, and CAGR from 2024 to 2031 |
|
Historic Year |
2019 to 2023 |
|
Forecast Year |
2024-2031 |
|
Report Coverage |
The forecast of revenue, the position of the company, the competitive market statistics, growth prospects, and trends |
|
Segments Covered |
Type, Application And End-Use |
|
Regional scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; France; Italy; Spain; South Korea; Southeast Asia |
|
Competitive Landscape |
Thermo Fisher Scientific, Inc.; Merck KGaA; Danaher; Lonza; Hoffmann-La Roche Ltd; Sartorius AG; AstraZeneca; Bristol-Myers Squibb; Amgen; Gilead Sciences; Moderna, Inc.; Regeneron Pharmaceuticals. |
|
Customization scope |
Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing and available payment methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Mammalian Cell Fermentation Technology Market Snapshot
Chapter 4. Global Mammalian Cell Fermentation Technology Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter’s Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: by Type Estimates & Trend Analysis
5.1. by Type & Market Share, 2023 & 2031
5.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Type:
5.2.1. Chinese Hamster Ovary (CHO) Cell Fermentation
5.2.2. Human Embryonic Kidney (HEK) Cell Fermentation
5.2.3. Baby Hamster Kidney (BHK) Cell Fermentation
5.2.4. Murine Myeloma Cell Fermentation
5.2.5. Medical Research Council Cell Strain - 5 (MRC-5) Fermentation
5.2.6. Others
Chapter 6. Market Segmentation 2: by Application Estimates & Trend Analysis
6.1. by Application & Market Share, 2023 & 2031
6.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Application:
6.2.1. Monoclonal Antibodies
6.2.2. Recombinant Proteins
6.2.3. Biosimilars
6.2.4. Vaccines
6.2.5. Enzymes
6.2.6. Others
Chapter 7. Market Segmentation 3: by End-use Estimates & Trend Analysis
7.1. by End-use & Market Share, 2023 & 2031
7.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by End-use:
7.2.1. Biopharmaceutical Companies
7.2.2. CMOs & CDMOs
7.2.3. Academic and Research Institutes
Chapter 8. Mammalian Cell Fermentation Technology Market Segmentation 4: Regional Estimates & Trend Analysis
8.1. North America
8.1.1. North America Mammalian Cell Fermentation Technology Market Revenue (US$ Million) Estimates and Forecasts by Type, 2024-2031
8.1.2. North America Mammalian Cell Fermentation Technology Market Revenue (US$ Million) Estimates and Forecasts by Application, 2024-2031
8.1.3. North America Mammalian Cell Fermentation Technology Market Revenue (US$ Million) Estimates and Forecasts by End-use, 2024-2031
8.1.4. North America Mammalian Cell Fermentation Technology Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
8.2. Europe
8.2.1. Europe Mammalian Cell Fermentation Technology Market Revenue (US$ Million) Estimates and Forecasts by Type, 2024-2031
8.2.2. Europe Mammalian Cell Fermentation Technology Market Revenue (US$ Million) Estimates and Forecasts by Application, 2024-2031
8.2.3. Europe Mammalian Cell Fermentation Technology Market Revenue (US$ Million) Estimates and Forecasts by End-use, 2024-2031
8.2.4. Europe Mammalian Cell Fermentation Technology Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
8.3. Asia Pacific
8.3.1. Asia Pacific Mammalian Cell Fermentation Technology Market Revenue (US$ Million) Estimates and Forecasts by Type, 2024-2031
8.3.2. Asia Pacific Mammalian Cell Fermentation Technology Market Revenue (US$ Million) Estimates and Forecasts by Application, 2024-2031
8.3.3. Asia-Pacific Mammalian Cell Fermentation Technology Market Revenue (US$ Million) Estimates and Forecasts by End-use, 2024-2031
8.3.4. Asia Pacific Mammalian Cell Fermentation Technology Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
8.4. Latin America
8.4.1. Latin America Mammalian Cell Fermentation Technology Market Revenue (US$ Million) Estimates and Forecasts by Type, 2024-2031
8.4.2. Latin America Mammalian Cell Fermentation Technology Market Revenue (US$ Million) Estimates and Forecasts by Application, 2024-2031
8.4.3. Latin America Mammalian Cell Fermentation Technology Market Revenue (US$ Million) Estimates and Forecasts by End-use, 2024-2031
8.4.4. Latin America Mammalian Cell Fermentation Technology Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
8.5. Middle East & Africa
8.5.1. Middle East & Africa Mammalian Cell Fermentation Technology Market Revenue (US$ Million) Estimates and Forecasts by Type, 2024-2031
8.5.2. Middle East & Africa Mammalian Cell Fermentation Technology Market Revenue (US$ Million) Estimates and Forecasts by Application, 2024-2031
8.5.3. Middle East & Africa Mammalian Cell Fermentation Technology Market Revenue (US$ Million) Estimates and Forecasts by End-use, 2024-2031
8.5.4. Middle East & Africa Mammalian Cell Fermentation Technology Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
Chapter 9. Competitive Landscape
9.1. Major Mergers and Acquisitions/Strategic Alliances
9.2. Company Profiles
9.2.1. Thermo Fisher Scientific, Inc.
9.2.2. Merck KGaA
9.2.3. Danaher
9.2.4. Lonza
9.2.5. Hoffmann-La Roche Ltd
9.2.6. Sartorius AG
9.2.7. AstraZeneca
9.2.8. Bristol-Myers Squibb
9.2.9. Amgen
9.2.10. Gilead Sciences
9.2.11. Moderna, Inc.
9.2.12. Regeneron Pharmaceuticals
9.2.13. Other Prominent Players
Mammalian Cell Fermentation Technology Market By Type
Mammalian Cell Fermentation Technology Market By Application
Mammalian Cell Fermentation Technology Market By End-Use
Mammalian Cell Fermentation Technology Market By Region-
North America-
Europe-
Asia-Pacific-
Latin America-
Middle East & Africa-
InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.
Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.
Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.
Secondary research
The secondary research sources that are typically mentioned to include, but are not limited to:
The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista
Primary Research:
Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies
The contributors who typically take part in such a course include, but are not limited to:
Data Modeling and Analysis:
In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.
The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.
To know more about the research methodology used for this study, kindly contact us/click here.
